Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Oct 20;55(41):1120-4. Erratum in: MMWR Morb Mortal Wkly Rep. 2006 Nov 3;55(43):1177.

2.

Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, October 2005-February 2006.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Apr 7;55(13):364-6.

3.

Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2005 Oct 14;54(40):1023-5.

4.

Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.

Velentgas P, Amato AA, Bohn RL, Chan KA, Cochrane T, Funch DP, Dashevsky I, Duddy AL, Gladowski P, Greenberg SA, Kramer JM, McMahill-Walraven C, Nakasato C, Spettell CM, Syat BL, Wahl PM, Walker AM, Zhang F, Brown JS, Platt R.

Pharmacoepidemiol Drug Saf. 2012 Dec;21(12):1350-8. doi: 10.1002/pds.3321. Epub 2012 Jul 16.

PMID:
22807266
5.

MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.

Cho BH, Clark TA, Messonnier NE, Ortega-Sanchez IR, Weintraub E, Messonnier ML.

Vaccine. 2010 Jan 8;28(3):817-22. doi: 10.1016/j.vaccine.2009.10.050. Epub 2009 Oct 30.

PMID:
19879992
6.
7.

Syncope after vaccination--United States, January 2005-July 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 May 2;57(17):457-60.

8.

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents.

Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM; V59P13 Study Group.

Clin Infect Dis. 2009 Jul 1;49(1):e1-10. doi: 10.1086/599117.

PMID:
19476428
9.

Use of meningococcal vaccines in the United States.

Bilukha O, Messonnier N, Fischer M.

Pediatr Infect Dis J. 2007 May;26(5):371-6. Review.

PMID:
17468644
10.

Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.

Souayah N, Nasar A, Suri MF, Qureshi AI.

Vaccine. 2007 Jul 20;25(29):5253-5. Epub 2007 May 22.

PMID:
17560693
11.

Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine.

[No authors listed]

Ann Pharmacother. 2006 May;40(5):1007. Epub 2006 May 2. No abstract available.

PMID:
16670362
12.

Letter to the Editor. Guillain-Barré Syndrome(GBS) after vaccination reported to the United States Vaccine Adverse Event Reporting System(VAERS) in 2004.

Haber P, Slade B, Iskander J.

Vaccine. 2007 Nov 23;25(48):8101. Epub 2007 Oct 1. No abstract available.

PMID:
17933441
13.
14.

Meningococcal tetravalent conjugate vaccine.

Smith MJ.

Expert Opin Biol Ther. 2008 Dec;8(12):1941-6. doi: 10.1517/14712590802538455 . Review.

PMID:
18990080
15.

Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.

De Wals P, Deceuninck G, Boucher RM, Ouakki M.

Clin Infect Dis. 2008 Apr 15;46(8):e75-7. doi: 10.1086/533469.

PMID:
18444843
16.

Inadvertent misadministration of meningococcal conjugate vaccine--United States, June-August 2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2006 Sep 22;55(37):1016-7.

17.

Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009.

Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, Qureshi AI.

Vaccine. 2011 Jan 29;29(5):886-9. doi: 10.1016/j.vaccine.2010.09.020. Epub 2010 Sep 23.

PMID:
20869467
18.

Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).

Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI.

J Clin Neuromuscul Dis. 2012 Dec;14(2):66-71. doi: 10.1097/CND.0b013e31824db14e.

PMID:
23172385
19.

Guillain-Barré syndrome following influenza vaccination.

Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT.

JAMA. 2004 Nov 24;292(20):2478-81.

PMID:
15562126
20.

A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study.

Velentgas P, Bohn RL, Brown JS, Chan KA, Gladowski P, Holick CN, Kramer JM, Nakasato C, Spettell CM, Walker AM, Zhang F, Platt R.

Pharmacoepidemiol Drug Saf. 2008 Dec;17(12):1226-34. doi: 10.1002/pds.1675.

PMID:
18956428

Supplemental Content

Support Center